Literature DB >> 23720266

Nuclear receptor control of enterohepatic circulation.

Frank J Gonzalez1.   

Abstract

Enterohepatic circulation is responsible for the capture of bile acids and other steroids produced or metabolized in the liver and secreted to the intestine, for reabsorption back into the circulation and transport back to the liver. Bile acids are secreted from the liver in the form of mixed micelles that also contain phosphatidylcholines and cholesterol that facilitate the uptake of fats and vitamins from the diet due to the surfactant properties of bile acids and lipids. Bile acids are synthesized in the liver from cholesterol by a cascade of enzymes that carry out oxidation and conjugation reactions, and transported to the bile duct and gall bladder where they are stored before being released into the intestine. Bile flow from the gall bladder to the small intestine is triggered by food intake in accordance with its role in lipid and vitamin absorption from the diet. Bile acids are further metabolized by gut bacteria and are transported back to the circulation. Metabolites produced in the liver are termed primary bile acids or primary conjugated bile salts, while the metabolites generated by bacterial are called secondary bile acids. About 95% of bile acids are reabsorbed in the proximal and distal ileum into the hepatic portal vein and then into the liver sinusoids, where they are efficiently transported into the liver with little remaining in circulation. Each bile acid is reabsorbed about 20 times on average before being eliminated. Enterohepatic circulation is under tight regulation by nuclear receptor signaling, notably by the farnesoid X receptor (FXR).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23720266      PMCID: PMC6608752          DOI: 10.1002/cphy.c120007

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  24 in total

Review 1.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

Review 2.  An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.

Authors:  Frank J Gonzalez; Changtao Jiang; Andrew D Patterson
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

4.  Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?

Authors:  Nobuhiro Nakamoto; Bernd Schnabl
Journal:  Inflamm Intest Dis       Date:  2016-01-20

5.  Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.

Authors:  Fan Yang; Yao Wang; Gang Li; Juan Xue; Zhi-Lin Chen; Feng Jin; Lei Luo; Xuan Zhou; Qian Ma; Xin Cai; Hua-Rong Li; Lei Zhao
Journal:  Br J Pharmacol       Date:  2018-01-25       Impact factor: 8.739

6.  Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.

Authors:  Kenneth Ng; Barbara Stoll; Shaji Chacko; Miguel Saenz de Pipaon; Charlotte Lauridsen; Matthew Gray; E James Squires; Juan Marini; Irving J Zamora; Oluyinka O Olutoye; Douglas G Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-01-16       Impact factor: 4.016

7.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

9.  Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.

Authors:  Shogo Takahashi; Tatsuki Fukami; Yusuke Masuo; Chad N Brocker; Cen Xie; Kristopher W Krausz; C Roland Wolf; Colin J Henderson; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2016-09-16       Impact factor: 5.922

10.  Deletion of Intestinal SHP Impairs Short-term Response to Cholic Acid Challenge in Male Mice.

Authors:  James T Nguyen; Ryan Riessen; Tongyu Zhang; Collin Kieffer; Sayeepriyadarshini Anakk
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.